Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2025-12-25 @ 1:20 AM
NCT ID:
NCT02032693
Eligibility Criteria:
Inclusion Criteria:
* Be between the ages of 18 and 55
* Live independently without medical assistance
* Willing to provide informed consent to participate in the study
* Willing to follow our procedures and requirements for the study, including:
1. providing blood, urine, and saliva samples
2. completing other assessments
* Patients may take a similar dietary supplement as the one used in the study, but they must stop taking all similar dietary supplements 2 weeks prior to starting the study and for the 6 weeks duration of the study.
Exclusion Criteria:
* Patients need to be free of major medical conditions, such as neurological, cardiovascular, pulmonary, renal, endocrine, thyroid, hepatic, autoimmune, or bone/joint disorders or conditions; psychiatric diagnoses or psychotic disorders, and have no gastrointestinal disorders that could affect how the dietary supplement is absorbed by their body.
* Cannot participate in another similar research trial within 30 days of participating in this study
* Cannot be a smoker or have stopped smoking less than 6 months ago
* Cannot currently be taking any chemotherapy or radiation treatment for cancer
* Cannot be diagnosed with a terminal illness
* Cannot be diagnosed with insulin-dependent diabetes and/or be taking metformin
* Cannot be HIV positive
* If female, the patient cannot currently be pregnant, breastfeeding, or intending to become pregnant within the next month
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT02032693
Study Brief:
Protocol Section:
NCT02032693